Automated VMAT planning in Pinnacle3: a dosimetric study in high-risk prostate cancer

被引：0
|
作者：
Cilla, S. [1 ]
Ianiro, A. [1 ]
Viola, P. [1 ]
Macchia, G. [2 ]
Buwenge, M. [3 ]
Arcelli, A. [3 ]
Cammelli, S. [3 ]
Valentini, V. [4 ]
Morganti, A. G. [3 ]
Deodato, F. [2 ]
机构：
[1] Univ Cattolica Sacro Cuore, Fdn Ric & Cura Giovanni Paolo II, Med Phys Unit, Campobasso, Italy
[2] Univ Cattolica Sacro Cuore, Fdn Ric & Cura Giovanni Paolo II, Radiat Oncol Unit, Campobasso, Italy
[3] Univ Bologna, S Orsola Malpighi Hosp, Dept Expt Diagnost & Specialty Med, DIMES,Radiat Oncol Dept, Bologna, Italy
[4] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, Radiat Oncol Dept, Rome, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 133卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1868
引用
收藏
页码：S1014 / S1014
页数：1
相关论文
共 50 条
  • [11] Fully automated VMAT technique for radiation therapy of high-risk breast cancer
    Redapi, L.
    Marrazzo, L.
    Pellegrini, R.
    Voet, P.
    Meattini, I.
    Arilli, C.
    Casati, M.
    Compagnucci, A.
    Talamonti, C.
    Zani, M.
    Livi, L.
    Pallotta, S.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S248 - S250
  • [12] Aspects of commissioning the Pinnacle3 Treatment Planning System for high-precision Conformal radiotherapy
    Mosleh-Shirazi, MA
    Hansen, VN
    Warrington, AP
    Childs, PJ
    Verhaegen, F
    Bedford, JL
    MEDICAL PHYSICS, 2002, 29 (06) : 1250 - 1250
  • [13] Planning and dosimetric evaluation of multi criteria optimization (MCO) for VMAT prostate cancer
    Mazouni, Z.
    Matzinger, O.
    Lacombe, C.
    Pachoud, M.
    Gandhour, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (01) : 96 - 96
  • [14] Dosimetric advantages of daily adaptive strategy in IMPT for high-risk prostate cancer
    Tamura, Hiroshi
    Kobashi, Keiji
    Nishioka, Kentaro
    Yoshimura, Takaaki
    Hashimoto, Takayuki
    Shimizu, Shinichi
    Ito, Yoichi M.
    Maeda, Yoshikazu
    Sasaki, Makoto
    Yamamoto, Kazutaka
    Tamamura, Hiroyasu
    Aoyama, Hidefumi
    Shirato, Hiroki
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2022, 23 (04):
  • [15] DOSIMETRIC COMPARISON AND TOXICITY ANALYSIS OF STEREOTACTIC RADIOTHERAPY FOR HIGH-RISK PROSTATE CANCER
    Callan, Laura
    Bauman, Glenn
    Chen, Jeff
    Lock, Michael
    Sexton, Tracy
    D'Souza, David
    Rodrigues, George
    RADIOTHERAPY AND ONCOLOGY, 2019, 139 : S17 - S18
  • [16] Extreme hypofractionation for high-risk prostate cancer: Dosimetric correlations with rectal bleeding
    Bauman, Glenn
    Chen, Jeff
    Rodrigues, George
    Davidson, Melanie
    Warner, Andrew
    Loblaw, Andrew
    PRACTICAL RADIATION ONCOLOGY, 2017, 7 (06) : E457 - E462
  • [17] Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer
    Li, XA
    Wang, JZ
    Jursinic, PA
    Lawton, CA
    Wang, D
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (04): : 1251 - 1257
  • [18] Dosimetric Comparison and Toxicity Analysis of Stereotactic Radiotherapy for High-Risk Prostate Cancer
    Callan, L.
    Bauman, G. S.
    Chen, J.
    Lock, M. I.
    Sexton, T. L.
    D'Souza, D. P.
    Rodrigues, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E268 - E269
  • [19] VMAT plan compared with variable and constant Dose rate including dosimetric Verification (Varian Clinac 2300C/D, Pinnacle3, ArcCHECK)
    Suess, C.
    Mueller, J.
    Bummer, J.
    Wilhelm, C.
    Treiber, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 161 - 161
  • [20] VMAT vs Eight Field Imrt: Dosimetric Comparison of Pelvic Radiotherapy for Patients with High-Risk Prostate Cancer in Terms of Bone Marrow Sparing
    Sezen, Duygu
    Alpan, Vildan
    Bolukbasi, Yasemin
    Saglam, Yucel
    Selek, Ugur
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2019, 34 (03): : 137 - 144
12345